ITGR
Integer Holdings Corporation NYSE Listed Sep 29, 2000$87.97
Mkt Cap $3.0B
52w Low $62.00
42.0% of range
52w High $123.78
50d MA $85.93
200d MA $88.81
P/E (TTM)
28.4x
EV/EBITDA
13.7x
P/B
1.7x
Debt/Equity
0.8x
ROE
5.9%
P/FCF
25.9x
RSI (14)
—
ATR (14)
—
Beta
0.71
50d MA
$85.93
200d MA
$88.81
Avg Volume
784.3K
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
5830 Granite Parkway · Plano, TX 75024 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | BMO | 1.21 | 1.20 | -0.8% | 83.67 | -7.9% | +5.8% | -5.1% | -0.1% | +2.3% | +0.5% | — |
| Feb 19, 2026 | BMO | 1.70 | 1.76 | +3.5% | 86.48 | +15.6% | -4.0% | +2.2% | +1.1% | +1.6% | -0.7% | — |
| Oct 23, 2025 | BMO | 1.68 | 1.79 | +6.5% | 109.11 | -20.1% | -32.3% | -1.3% | -3.7% | -3.1% | -4.0% | — |
| Jul 24, 2025 | BMO | 1.57 | 1.55 | -1.3% | 115.77 | -3.2% | -7.5% | +1.3% | -0.3% | +1.0% | -0.4% | — |
| Apr 24, 2025 | BMO | 1.27 | 1.31 | +3.1% | 120.51 | +3.1% | +0.8% | +1.6% | -0.5% | +3.4% | -0.5% | — |
| Feb 20, 2025 | BMO | 1.46 | 1.43 | -2.1% | 143.21 | -0.8% | -5.6% | -4.0% | -2.2% | +0.6% | -1.2% | — |
| Oct 24, 2024 | BMO | 1.36 | 1.43 | +5.1% | 126.53 | -4.1% | +0.2% | -0.8% | +1.7% | +1.7% | -0.1% | — |
| Jul 25, 2024 | BMO | 1.24 | 1.30 | +4.8% | 124.55 | -5.0% | -7.1% | +1.0% | +2.5% | +1.4% | -2.2% | — |
| Apr 25, 2024 | BMO | 1.12 | 1.14 | +1.8% | 123.27 | -7.5% | -9.8% | -1.4% | +4.6% | -2.6% | -1.7% | — |
| Feb 15, 2024 | BMO | 1.34 | 1.39 | +3.7% | 105.05 | -1.4% | -5.0% | -0.4% | +0.9% | -1.7% | +1.6% | — |
| Oct 26, 2023 | BMO | 1.05 | 1.27 | +21.0% | 69.42 | +5.7% | +15.6% | -1.7% | +1.9% | +1.0% | +1.5% | — |
| Jul 27, 2023 | BMO | 0.99 | 1.14 | +15.2% | 86.99 | +5.7% | +7.2% | -1.6% | +0.8% | +0.2% | -0.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Piper Sandler | Maintains | Overweight → Overweight | — | $88.51 | $87.85 | -0.7% | -5.1% | -0.1% | +2.3% | +0.5% | +1.9% |
| May 1 | Citigroup | Maintains | Neutral → Neutral | — | $88.51 | $87.85 | -0.7% | -5.1% | -0.1% | +2.3% | +0.5% | +1.9% |
| Feb 20 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $83.00 | $83.00 | +0.0% | +2.2% | +1.1% | +1.6% | -0.7% | +0.3% |
| Feb 20 | Truist | Maintains | Buy → Buy | — | $83.00 | $83.00 | +0.0% | +2.2% | +1.1% | +1.6% | -0.7% | +0.3% |
| Feb 20 | Citigroup | Maintains | Neutral → Neutral | — | $83.00 | $83.00 | +0.0% | +2.2% | +1.1% | +1.6% | -0.7% | +0.3% |
| Feb 20 | Benchmark | Upgrade | Hold → Buy | — | $83.00 | $83.00 | +0.0% | +2.2% | +1.1% | +1.6% | -0.7% | +0.3% |
| Dec 18 | Truist | Maintains | Buy → Buy | — | $74.13 | $76.00 | +2.5% | +5.9% | +0.1% | +0.8% | -1.8% | +1.2% |
| Dec 11 | Citigroup | Maintains | Neutral → Neutral | — | $71.95 | $72.13 | +0.3% | +0.5% | +0.5% | +0.5% | +1.1% | +0.3% |
| Nov 24 | Truist | Maintains | Buy → Buy | — | $70.00 | $69.93 | -0.1% | +1.7% | +0.3% | +0.9% | +0.2% | -0.6% |
| Nov 3 | Citigroup | Maintains | Neutral → Neutral | — | $64.57 | $64.57 | +0.0% | +3.7% | +2.5% | -0.7% | -2.2% | +2.4% |
| Oct 24 | Piper Sandler | Maintains | Overweight → Overweight | — | $73.89 | $71.57 | -3.1% | -1.3% | -3.7% | -3.1% | -4.0% | -3.0% |
| Oct 24 | Raymond James | Maintains | Outperform → Outperform | — | $73.89 | $71.57 | -3.1% | -1.3% | -3.7% | -3.1% | -4.0% | -3.0% |
| Oct 24 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $73.89 | $71.57 | -3.1% | -1.3% | -3.7% | -3.1% | -4.0% | -3.0% |
| Oct 24 | Benchmark | Downgrade | Buy → Hold | — | $73.89 | $71.57 | -3.1% | -1.3% | -3.7% | -3.1% | -4.0% | -3.0% |
| Oct 24 | Truist | Maintains | Buy → Buy | — | $73.89 | $71.57 | -3.1% | -1.3% | -3.7% | -3.1% | -4.0% | -3.0% |
| Oct 24 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $73.89 | $71.57 | -3.1% | -1.3% | -3.7% | -3.1% | -4.0% | -3.0% |
| Oct 24 | Citigroup | Downgrade | Buy → Neutral | — | $73.89 | $71.57 | -3.1% | -1.3% | -3.7% | -3.1% | -4.0% | -3.0% |
| Oct 21 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $107.37 | $106.40 | -0.9% | +0.5% | +1.1% | -32.3% | -1.3% | -3.7% |
| Oct 15 | Truist | Maintains | Buy → Buy | — | $103.97 | $103.32 | -0.6% | -0.2% | -0.7% | +1.7% | +2.4% | +0.5% |
| Jul 25 | Raymond James | Maintains | Outperform → Outperform | — | $107.10 | $107.10 | +0.0% | +1.3% | -0.3% | +1.0% | -0.4% | -0.2% |
| Jul 25 | Truist | Maintains | Buy → Buy | — | $107.10 | $107.10 | +0.0% | +1.3% | -0.3% | +1.0% | -0.4% | -0.2% |
| Jul 25 | Wells Fargo | Maintains | Overweight → Overweight | — | $107.10 | $107.10 | +0.0% | +1.3% | -0.3% | +1.0% | -0.4% | -0.2% |
| May 22 | Citigroup | Upgrade | Neutral → Buy | — | $118.88 | $120.07 | +1.0% | -0.6% | +0.1% | +2.8% | -1.8% | +0.1% |
| Apr 28 | Truist | Maintains | Buy → Buy | — | $123.41 | $123.41 | +0.0% | -0.5% | +3.4% | -0.5% | -0.6% | +0.1% |
| Apr 25 | Raymond James | Maintains | Outperform → Outperform | — | $121.46 | $121.59 | +0.1% | +1.6% | -0.5% | +3.4% | -0.5% | -0.6% |
| Apr 25 | Benchmark | Maintains | Buy → Buy | — | $121.46 | $121.59 | +0.1% | +1.6% | -0.5% | +3.4% | -0.5% | -0.6% |
| Apr 21 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $116.98 | $115.87 | -0.9% | -1.3% | +2.2% | +2.1% | +0.8% | +1.6% |
| Apr 11 | Truist | Maintains | Buy → Buy | — | $113.83 | $113.85 | +0.0% | +2.3% | +1.3% | -0.9% | -0.6% | +0.7% |
| Feb 21 | Benchmark | Maintains | Buy → Buy | — | $135.22 | $135.73 | +0.4% | -4.0% | -2.2% | +0.6% | -1.2% | -2.0% |
| Feb 20 | Citigroup | Maintains | Neutral → Neutral | — | $143.21 | $142.00 | -0.8% | -5.6% | -4.0% | -2.2% | +0.6% | -1.2% |
| Jan 24 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $143.28 | $142.50 | -0.5% | -0.6% | +0.5% | +0.9% | -0.8% | +0.2% |
| Dec 11 | Citigroup | Maintains | Neutral → Neutral | — | $139.64 | $141.04 | +1.0% | +0.7% | -0.9% | -0.4% | -0.2% | -1.2% |
| Dec 11 | Truist | Maintains | Buy → Buy | — | $139.64 | $141.04 | +1.0% | +0.7% | -0.9% | -0.4% | -0.2% | -1.2% |
| Oct 25 | Piper Sandler | Maintains | Overweight → Overweight | — | $126.76 | $128.63 | +1.5% | -0.8% | +1.7% | +1.7% | -0.1% | -4.4% |
| Oct 25 | Benchmark | Maintains | Buy → Buy | — | $126.76 | $128.63 | +1.5% | -0.8% | +1.7% | +1.7% | -0.1% | -4.4% |
| Oct 25 | Truist | Maintains | Buy → Buy | — | $126.76 | $128.63 | +1.5% | -0.8% | +1.7% | +1.7% | -0.1% | -4.4% |
| Oct 21 | Benchmark | Maintains | Buy → Buy | — | $130.43 | $130.10 | -0.3% | -2.0% | -1.8% | +0.8% | +0.2% | -0.8% |
| Oct 15 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $132.43 | $132.32 | -0.1% | -0.7% | -0.3% | -0.5% | +0.0% | -2.0% |
| Oct 14 | Truist | Maintains | Buy → Buy | — | $129.24 | $130.14 | +0.7% | +2.5% | -0.7% | -0.3% | -0.5% | +0.0% |
| Oct 2 | Benchmark | Maintains | Buy → Buy | — | $127.19 | $126.43 | -0.6% | +0.0% | -1.1% | +2.6% | -0.3% | +0.4% |
| Oct 1 | BofA Securities | Maintains | Buy → Buy | — | $130.00 | $130.49 | +0.4% | -2.2% | +0.0% | -1.1% | +2.6% | -0.3% |
| Oct 1 | Truist | Maintains | Buy → Buy | — | $130.00 | $130.49 | +0.4% | -2.2% | +0.0% | -1.1% | +2.6% | -0.3% |
| Oct 1 | Citigroup | Maintains | Neutral → Neutral | — | $130.00 | $130.49 | +0.4% | -2.2% | +0.0% | -1.1% | +2.6% | -0.3% |
| Aug 2 | Benchmark | Maintains | Buy → Buy | — | $116.16 | $113.69 | -2.1% | -3.8% | -1.4% | +2.0% | +0.5% | +1.3% |
| May 22 | Citigroup | Maintains | Neutral → Neutral | — | $121.31 | $121.39 | +0.1% | +0.2% | +0.2% | +0.7% | -1.0% | +0.0% |
| May 10 | Benchmark | Maintains | Buy → Buy | — | $114.23 | $114.40 | +0.1% | -0.2% | -1.1% | -0.6% | +5.1% | +1.1% |
| Apr 26 | Benchmark | Maintains | Buy → Buy | — | $111.15 | $110.54 | -0.5% | -1.4% | +4.6% | -2.6% | -1.7% | +0.1% |
| Apr 15 | BofA Securities | Upgrade | Neutral → Buy | — | $115.77 | $118.68 | +2.5% | +2.5% | +0.6% | -0.7% | -0.6% | -1.0% |
| Apr 9 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $115.40 | $117.52 | +1.8% | +3.1% | -3.0% | +1.3% | -1.0% | +2.5% |
| Mar 28 | Benchmark | Maintains | Buy → Buy | — | $115.06 | $116.70 | +1.4% | +1.4% | -0.6% | -1.2% | +1.4% | -1.0% |
No insider trades available.
8-K · 7.01
! Medium
Integer Holdings Corporation -- 8-K 7.01: Regulation FD Disclosure
Integer Holdings Corporation's board initiated a strategic review process to evaluate options for maximizing shareholder value, signaling potential significant corporate actions ahead.
Apr 30
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
The departure of an executive at Integra LifeSciences (ITGR) signals potential leadership instability and may create near-term uncertainty around strategic direction and operational continuity.
Mar 12
8-K · 7.01
! Medium
Integer Holdings Corporation -- 8-K 7.01: Regulation FD Disclosure
Integer Holdings Corporation disclosed non-binding information via Regulation FD, indicating the company shared material details with investors but avoided formal filing obligations under securities law.
Feb 19
Data updated apr 25, 2026 4:23pm
· Source: massive.com